Background Erectile dysfunction (ED) has been suggested to be associated with an increased risk of cardiovascular disease (CVD), including coronary artery disease, stroke, and cardiovascular mortality This meta-analysis aims to investigate the relationship between ED and CVD risk using PRISMA 2020 guidelines for reporting systematic reviews and evaluate the risk of specific cardiovascular events such as coronary artery disease (CAD), myocardial infarction (MI), stroke, and cardiovascular mortality.

Methods A systematic literature search was conducted in PubMed, Embase, Cochrane Library, and Web of Science databases from January 2009 to December 2023. Studies were selected based on predefined inclusion criteria. Data extraction and quality assessment were performed independently by two reviewers. Pooled relative risks (RRs) with 95% confidence intervals (CIs) were calculated using a random-effects model. Heterogeneity was assessed using the I² statistic and Q test.

For the assessment of certainty were used the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach to assess the certainty of evidence for each outcome. The GRADE approach evaluates evidence based on five domains: risk of bias, inconsistency, indirectness, imprecision, and publication bias. Each domain can lead to downgrading the certainty of evidence by one or two levels. The overall certainty of evidence was classified as high, moderate, low, or very low.

Results This updated meta-analysis of prospective studies provides robust evidence that ED was found to be an independent risk factor for CVD outcomes, including coronary artery disease, stroke, and cardiovascular mortality. Clinicians should consider early identification and management of ED, such initiative has great potential to improve cardiovascular risk and using it as stratification criteria would help CVD prevention strategies in men.

The authors have declared no competing interest.

This study did not receive any funding

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

The data underlying this meta-analysis are available from the corresponding author upon request.